Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease
Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorVirginia Commonwealth University
About this trial
The purpose of this research study is to test the safety, tolerability, and effectiveness of the capsules that contain bacteria from healthy individuals when used to treat alcohol craving and drinking.
Eligibility criteria
Qualifiers
Advanced liver disease
Able to give written, informed consent
Alcohol as a cause of advanced liver disease
Continued sustained drinking
Disqualifiers
Lack of sustained drinking
Recent or current alcoholic hepatitis
Alcohol withdrawal symptoms
Clinically significant use of illicit drugs
Trial design
Treatments tested in this trial
- Intestinal Microbiota Transplant (IMT) Capsules
- Placebo Capsules
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
Virginia Commonwealth University
Lead sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator
Source ClinicalTrials.gov